Pain Update Conference 2014

AIM Health Group division of Viable Healthworks Annual Pain Update Conference held at the Delta Meadowvale Hotel & Conference Centre on Friday, September 19, 2014. 

A special thanks goes out to our many speakers and sponsors!


Dr. Jackie Gardner-Nix – Mindfulness based Pain Management
Dr. Roman Jovey – Pharmacotherapy Update – Something Old and New
Dr. Julia Alleyne – Physical Rehab Approaches to Chronic Pain – What Works?
Dr. Joel Bordman – Managing Pain and Addiction – Evolving Strategies
Dr. Gordon Ko – Injections for Pain – An Update



Purdue Pharma  Canada Purdue Pharma Canada is dedicated to developing and providing innovative medicines for patients and healthcare professionals and to supporting quality education for the safe use of its products.


Allergan, Inc. Allergan Inc. is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, biologics, medical devices and over-the-counter consumer products that enable people to live life to its greatest potential — to see more clearly, move more freely, express themselves more fully.

Lilly Lilly makes medicines that help people live longer, healthier, more active lives.

Lilly Canada was founded in 1938, and has since grown into a leading research-based pharmaceutical company. Eli Lilly Canada built its first facility in 1946 and the Canadian headquarters are still located on this site in Toronto, Ontario. Today, the company employs more than 500 people across the country.

Medical Futures Inc. Medical Futures Inc. is a niche pharmaceutical company that sells both pharmaceutical and natural therapeutic products into the North American marketplace. Founded in 2000, Medical Futures is privately owned and based in Richmond Hill, Ontario.

Merck Merck is committed to improving health and well-being around the world. From developing new therapies that treat and prevent disease to helping people in need, we are guided by a rich legacy and inspired by a shared vision.

Mylan Pharmaceuticals below Merck At Mylan, we are committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what’s right, not what’s easy; and impact the future through passionate global leadership.